Amsterdam institute for Immunology and Infectious diseases

Correspondence on ‘Radiographic structural damage in axial spondyloarthritis: is there a preferred way to quantify progression over time? Comparison of blinded versus unblinded mSASSS scoring’ by Protopopov et al

Landewé, R. B. M. & van der Heijde, D., 1 Oct 2025, In: Annals of the rheumatic diseases. 84, 10, p. e45-e46

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis

Ulijn, E., den Broeder, N., Bevers, K., Pruijs, R., van Es, B., Tauber, T., Landewe, R., van Herwaarden, N. & den Broeder, A. A., 1 Oct 2025, In: Annals of Internal Medicine. 178, 10, p. 1400-1408 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?

Santos, M. E., Ramiro, S., van der Heijde, D. S., Landewé, R., Cruz-Machado, A. R., Ferreira, C. C., Marques-Gomes, C., Soares, C. D., Miguel, C., Albuquerque, F., Martins, F., Silva, L. G., Santos, H., Almeida, I., Bernardes, M., Khmelinskii, N., Valente, P., Teixeira, P. M., Matias, S. E. & Fraga, V. & 3 others, Pimentel-Santos, F., Branco, J. C. & Sepriano, A., 1 Oct 2025, In: Seminars in Arthritis and Rheumatism. 74, 152781.

Research output: Contribution to journal › Article › Academic › peer-review